Malusi Mtetwa: Tranexamic Acid – What Does the Evidence Tell Us?
Malusi Mtetwa, Academic Casual – Paramedicine at Charles Sturt University, Paramedic at South Australia Ambulance Service, shared a post on LinkedIn:
“ParaPodcast Podcast and CPD Activity: Tranexamic Acid (TXA) — What Does the Evidence Tell Us?
How did a low-cost medication change trauma care, and why do the findings differ across bleeding conditions?
In this episode of ParaPodcast: Paramedicine from Africa to the World, we are joined by Professor Ian Roberts to explore the evidence behind tranexamic acid (TXA), including the landmark CRASH and WOMAN trials, the HALT-IT trial, and the challenges of translating research into clinical practice.
We discuss the importance of early administration, the risks of extrapolating evidence between different bleeding conditions, trial design, and the patients who can be overlooked when research is translated into practice.”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 03:54Jennifer Trowbridge: How Mutant Blood Stem Cells Use Inflammation to Drive Their Own Expansion
-
Oct 19, 2026, 03:39Wyenona Hicks: Catching Up With Old Friends and New Colleagues at AABB 2026
-
Oct 19, 2026, 03:33Developing a Non-Invasive Treatment for Life-Threatening PE – University of Michigan College of Engineering
-
Oct 19, 2026, 03:28Jim Hoffman: How NETs Contribute to Gallstone Formation and Growth
-
Oct 19, 2026, 03:28Nicolas Hubacz: The Organized Chaos of Mitochondria
-
Oct 19, 2026, 03:02Neda Horvacki: Using ROTEM to Refine Transfusion Decisions in Acute Trauma
-
Oct 19, 2026, 02:45Diego Escarraman Martinez: MATTERs Study – When a Cohort Gave Us Major Clues about TXA in Trauma
-
Oct 19, 2026, 02:35Brian O Mahony: Promoting Physical Activity and Sport in Haemophilia Care
-
Oct 19, 2026, 02:34Rishabh Mishra: Does the Evidence Support Tranexamic Acid Formulations in Skincare?